Swift Lung Cancer Panel
Interrogate NSCLC and SCLC genes
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The Accel-Amplicon Plus Lung Cancer Panel takes variant discovery and screening to a whole new level. It combines content from peer reviewed publications and other sources to offer comprehensive and exon-level hotspot coverage of 17 clinically-relevant lung genes for both small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). But that’s just the beginning.
The panel is modular, allowing you to add focused content to achieve your most optimal design. Either choose from our pre-validated content or add your own targets. We’ll work alongside you to design your assay and then Swift will optimize and wet-bench validate its performance before shipping it to you.
Key features include:
- Robust performance on cell-free DNA and FFPE samples starting with as little as 10 ng input
- Sensitive detection of rare variants down to 1% allele frequency
- Easy, single-tube assay with sequence ready libraries in 2 hours
- Streamlined analysis with new bioinformatics tools including Primerclip or Genialis
- Compatible with all Illumina sequencers
